Olink Holding AB (OLK)
22.99
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
22.99
0.00 (0.00%)
After-Hours: 20:00
Olink Gross Profit Margin (Quarterly): 71.00% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 71.00% |
| September 30, 2023 | 69.96% |
| June 30, 2023 | 58.74% |
| March 31, 2023 | 64.15% |
| December 31, 2022 | 74.50% |
| September 30, 2022 | 66.06% |
| June 30, 2022 | 62.04% |
| March 31, 2022 | 58.72% |
| Date | Value |
|---|---|
| December 31, 2021 | 57.92% |
| September 30, 2021 | 62.13% |
| June 30, 2021 | 67.08% |
| March 31, 2021 | 63.34% |
| December 31, 2020 | 68.97% |
| September 30, 2020 | 71.09% |
| June 30, 2020 | 70.94% |
| March 31, 2020 | 55.63% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
55.63%
Minimum
Mar 2020
74.50%
Maximum
Dec 2022
65.14%
Average
65.10%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Thermo Fisher Scientific Inc | 41.61% |
| Abliva AB | -- |
| Karolinska Development AB | -- |
| Calliditas Therapeutics AB | 95.06% |
| Oncopeptides AB | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -6.71% |
| Return on Assets | -5.81% |
| Return on Invested Capital | -6.69% |
| Profit Margin (Quarterly) | -11.01% |
| Operating Margin (Quarterly) | -9.23% |
| Return on Net Operating Assets | -5.99% |